Empagliflozin and left atrial function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink‐6 randomized clinical trial oleh Marina Pourafkari, Kim A. Connelly, Subodh Verma, C. David Mazer, Hwee Teoh, Adrian Quan, Shaun G. Goodman, Archana Rai, Ming Yen Ng, Djeven P. Deva, Piero Triverio, Laura Jiminez-Juan, Andrew T. Yan, Yin Ge